3

OWNERSHIP DOCUMENT

Company: Ultragenyx Pharmaceutical Inc.
Filed: January 30, 2014
Period of Report: January 30, 2014
Accession Number: 0000903423-14-000034

View Document ↗ View on SEC.gov ↗